Cleared Traditional

K231797 - Medifun Lancing Device, Model No. LD-E1 (FDA 510(k) Clearance)

Nov 2023
Decision
155d
Days
Class 2
Risk

K231797 is an FDA 510(k) clearance for the Medifun Lancing Device, Model No. LD-E1. This device is classified as a Multiple Use Blood Lancet For Single Patient Use Only (Class II - Special Controls, product code QRL).

Submitted by Medifun Corporation (Taichung City, TW). The FDA issued a Cleared decision on November 22, 2023, 155 days after receiving the submission on June 20, 2023.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4850. A Multiple Use Capable Blood Lancet Intended For Use On A Single Patient That Is Comprised Of A Single Use Blade Attached To A Solid, Reusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes..

Submission Details

510(k) Number K231797 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 20, 2023
Decision Date November 22, 2023
Days to Decision 155 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QRL - Multiple Use Blood Lancet For Single Patient Use Only
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4850
Definition A Multiple Use Capable Blood Lancet Intended For Use On A Single Patient That Is Comprised Of A Single Use Blade Attached To A Solid, Reusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes.